Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
11.92x1.04x0.42x1.81x7.32x9.76x2.83% 6.4B
15.85x1.84x-2.3x3.42x9.24x10.11x0.64% 62.28B
29.67x4.42x2.29x6x17.19x22.11x0.53% 60.59B
32.01x6.45x0.62x10.82x20.41x24.16x-.--% 39.55B
-48.72x2.22x0.39x2.97x8.76x10.22x3.76% 36.8B
32.3x1.49x-1.09x3.5x10.57x12.52x-.--% 29.53B
16.54x3.22x6.96x2.97x9.18x8.97x-.--% 21.68B
-5.77x3.4x-0.3x7.76x-4.74x-4.5x-.--% 19.8B
49.09x4.89x0.26x5.22x37.5x34.16x-.--% 16.96B
24.58x3.44x0.02x5.09x13.72x19.1x-.--% 16.16B
-131.97x13515.36x2.78x13.21x-117.06x-132.09x-.--% 13.13B
-30.7x-5.33x0.72x14.49x-43.88x-45.62x-.--% 13.08B
61.66x25.28x0.58x38.61x54.23x55.83x0.15% 11.91B
15.89x - 0.17x3.42x12.53x15.02x-.--% 10.81B
40.79x - 2.92x - - - -.--% 9.37B
-112.15x - 7.43x - - - -.--% 5.52B
13.02x1.21x-0.19x2.23x5.77x6.95x1.72% 5.29B
54.64x3.86x-0.7x - - - - 5.19B
23.94x - 1.17x6.33x16.78x20.04x0.43% 4.89B
17.89x0.96x1.07x - - - - 4.85B
Average 5.52x 848.36x 1.16x 7.99x 3.60x 4.17x 0.56% 19.69B
Weighted average by Cap. 9.79x 492.21x 0.72x 6.83x 7.73x 9.10x 0.63%
Biopharmaceuticals
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!